Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer
about
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer
description
scientific article published on 12 March 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2019
@uk
name
Different incidence of interst ...... PD-1 antibodies in lung cancer
@en
Different incidence of interst ...... PD-1 antibodies in lung cancer
@nl
type
label
Different incidence of interst ...... PD-1 antibodies in lung cancer
@en
Different incidence of interst ...... PD-1 antibodies in lung cancer
@nl
prefLabel
Different incidence of interst ...... PD-1 antibodies in lung cancer
@en
Different incidence of interst ...... PD-1 antibodies in lung cancer
@nl
P2093
P921
P356
P1433
P1476
Different incidence of interst ...... PD-1 antibodies in lung cancer
@en
P2093
Atsuto Mouri
Ayako Shiono
Fuyumi Nishihara
Hiroshi Kagamu
Kosuke Hashimoto
Kunihiko Kobayashi
Ou Yamaguchi
Takahiro Uchida
Yoshitake Murayama
P304
P356
10.1111/1759-7714.13039
P407
P577
2019-03-12T00:00:00Z